CD79A: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 18:24, 18 March 2025
CD79A is a protein that in humans is encoded by the CD79A gene. It is also known as Ig-alpha (Immunoglobulin-alpha) and is a component of the B-cell antigen receptor (BCR). The CD79A molecule plays a crucial role in B cell development and antigen receptor signaling.
Function[edit]
CD79A and CD79B (Ig-beta) proteins are integral components of the B cell receptor (BCR) complex, which is involved in the development and maturation of B cells. The BCR complex plays a critical role in B cell activation and function. The CD79A molecule is necessary for initiating antigen receptor signals, which influence B cell development and immune response.
Clinical significance[edit]
Mutations in the CD79A gene have been associated with agammaglobulinemia-3, a type of primary immunodeficiency characterized by the failure of B cells to produce immunoglobulins. This condition leads to recurrent bacterial infections in affected individuals.
Interactions[edit]
CD79A has been shown to interact with CD79B, LYN, and Syk.
See also[edit]
References[edit]
<references />
External links[edit]
- CD79A at the US National Library of Medicine Medical Subject Headings (MeSH)


